KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.98

Mannitol for bowel preparation: Efficacy and safety results from the SATISFACTION randomised clinical trial.

Maurizio Vecchi, Gian Eugenio Tontini, Giancarla Fiori, Paolo Bocus, Marino Carnovali, Paola Cesaro, Guido Costamagna, Dhanai Di Paolo, Luca Elli, Olga Fedorishina, Carsten Hinkel, Ralf Jakobs, Sergey Kashin, Michela Magnoli, Gianpiero Manes, Ekaterina Melnikova, Anna Orsatti, Thierry Ponchon, Alberto Prada, Franco Radaelli, Sandro Sferrazza, Pietro Soru, Jean Christophe Valats, Victor Veselov, Cristiano Spada, Peter Uebel, SATISFACTION Study Group

Dig Liver Dis 57(2) 574-583

PMID39562215
PMCID-
DOI10.1016/j.dld.2024.09.024
发表日期2024-11-19
入排依据:未发现恶性肿瘤人群证据。
摘要

摘要

BACKGROUND: Bowel preparation represents a significant issue to high-quality colonoscopy. Oral mannitol requires a single dose, is of low volume, and has a pleasant taste and rapid action. AIMS: This SATISFACTION study compared single-dose (same day) oral mannitol 100 g/750 mL with standard split-dose PEG-ASC2 L (MoviPrep®). METHODS: The primary endpoint was the proportion of patients with adequate bowel cleansing. Secondary endpoints included efficacy (adenoma detection rate, caecal intubation rate, time of evacuation), safety (intestinal gases concentration, haemato-chemical parameters, adverse events), and patient satisfaction. RESULTS: The study included 703 patients (352 treated with mannitol and 351 with PEG-ASC). Mannitol was not inferior to PEG-ASC for the primary endpoint (91.1 % and 95.5 %, respectively; p-value for the non-inferiority =0.0131). There was no significant difference for secondary efficacy endpoints. The acceptability profile was significantly better in the mannitol group for ease of use, taste, and willingness to reuse (p < 0.0001 for all). The concentration of intestinal gases (H2, CH4) was similar between groups and well below those potentially critical. CONCLUSIONS: The SATISFACTION study indicated that low-volume, single-dose mannitol may satisfy an unmet clinical need since it was more acceptable to the patient and not inferior to the split-dose PEG-ASC for bowel cleansing efficacy.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。